Privia Health Group (NASDAQ:PRVA) Stock Price Expected to Rise, Robert W. Baird Analyst Says

Privia Health Group (NASDAQ:PRVA) had its price target lifted by Robert W. Baird from $24.00 to $26.00 in a report issued on Tuesday, Marketbeat.com reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s price objective points to a potential upside of 8.92% from the stock’s current price.

A number of other analysts have also recently commented on PRVA. Canaccord Genuity Group upped their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, February 28th. Barclays increased their price target on Privia Health Group from $21.00 to $23.00 and gave the stock an “equal weight” rating in a report on Thursday, April 10th. Truist Financial lifted their price objective on Privia Health Group from $27.00 to $28.00 and gave the company a “buy” rating in a report on Thursday, April 10th. Stephens reissued an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a research note on Thursday, January 2nd. Finally, Macquarie assumed coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. One research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Privia Health Group presently has a consensus rating of “Buy” and an average target price of $27.00.

Privia Health Group Price Performance

Privia Health Group stock opened at $23.87 on Tuesday. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $26.04. The firm has a market capitalization of $2.90 billion, a price-to-earnings ratio of 238.72, a PEG ratio of 3.47 and a beta of 0.88. The company’s 50 day simple moving average is $23.83 and its 200 day simple moving average is $21.59.

Insider Buying and Selling

In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the business’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the transaction, the chief financial officer now owns 179,676 shares of the company’s stock, valued at $4,021,148.88. The trade was a 3.04 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 14.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Privia Health Group

Several hedge funds and other institutional investors have recently made changes to their positions in the company. First Horizon Advisors Inc. lifted its stake in Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after acquiring an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after purchasing an additional 2,350 shares during the period. Financial Management Professionals Inc. bought a new position in Privia Health Group during the fourth quarter worth about $51,000. GAMMA Investing LLC increased its position in Privia Health Group by 113.1% during the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock worth $64,000 after buying an additional 1,521 shares during the last quarter. Finally, Quadrant Capital Group LLC raised its stake in Privia Health Group by 11.8% in the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock valued at $95,000 after buying an additional 511 shares during the period. 94.48% of the stock is owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.